Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation

被引：0
|
作者：
Rajendar K. Mittapalli
Silpa Nuthalapati
Alyssa E. Delke DeBord
Hao Xiong
机构：
[1] Clinical Pharmacology and Pharmacometrics,
[2] AbbVie Inc.,undefined
[3] Process Engineering Sciences,undefined
[4] Drug Product Development AbbVie Inc.,undefined
[5] ,undefined
来源：
Pharmaceutical Research | 2017年 / 34卷
关键词：
dissolution; extended-release formulation; correlations (IVIVC); pharmacokinetics; veliparib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1187 / 1192
页数：5
相关论文
共 50 条
  • [1] Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation
    Mittapalli, Rajendar K.
    Nuthalapati, Silpa
    DeBord, Alyssa E. Delke
    Xiong, Hao
    [J]. PHARMACEUTICAL RESEARCH, 2017, 34 (06) : 1187 - 1192
  • [2] Development of In Vitro-In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
    Mohamed, Mohamed-Eslam F.
    Trueman, Sheryl
    Othman, Ahmed A.
    Han, Jian-Hwa
    Ju, Tzuchi R.
    Marroum, Patrick
    [J]. AAPS JOURNAL, 2019, 21 (06):
  • [3] Development and Internal Validation of an In Vitro-in Vivo Correlation for a Hydrophilic Metoprolol Tartrate Extended Release Tablet Formulation
    Natalie D. Eddington
    Patrick Marroum
    Ramana Uppoor
    Ajaz Hussain
    Larry Augsburger
    [J]. Pharmaceutical Research, 1998, 15 : 466 - 473
  • [4] Development of In Vitro-In Vivo Correlation for Potassium Chloride Extended Release Tablet Formulation Using Urinary Pharmacokinetic Data
    Mittapalli, Rajendar K.
    Marroum, Patrick
    Qiu, Yihong
    Apfelbaum, Kathleen
    Xiong, Hao
    [J]. PHARMACEUTICAL RESEARCH, 2017, 34 (07) : 1527 - 1533
  • [5] Development of In Vitro-In Vivo Correlation for Potassium Chloride Extended Release Tablet Formulation Using Urinary Pharmacokinetic Data
    Rajendar K. Mittapalli
    Patrick Marroum
    Yihong Qiu
    Kathleen Apfelbaum
    Hao Xiong
    [J]. Pharmaceutical Research, 2017, 34 : 1527 - 1533
  • [6] Development of an Extended-Release Formulation for Apremilast and a Level A in Vitro-in Vivo Correlation Study in Beagle Dogs
    Tang, Meiqiong
    Hu, Ping
    Huang, Shigui
    Zheng, Qiang
    Yu, Hao
    He, Yun
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2016, 64 (11) : 1607 - 1615
  • [7] Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
    Mohamed-Eslam F. Mohamed
    Sheryl Trueman
    Ahmed A. Othman
    Jian-Hwa Han
    Tzuchi R. Ju
    Patrick Marroum
    [J]. The AAPS Journal, 21
  • [8] Extended release dosage form of glipizide:: Development and validation of a level A in vitro-in vivo correlation
    Ghosh, Animesh
    Bhaumik, Uttam Kumar
    Bose, Anirbandeep
    Mandal, Uttam
    Gowda, Veeran
    Chatterjee, Bappaditya
    Chakrabarty, Uday Sankar
    Pal, Tapan Kumar
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (10) : 1946 - 1951
  • [9] Development of a level A in vitro-in vivo correlation for extended release dosage forms of quetiapine fumarate
    Goncalves de Lima, L.
    Rossi de Campos, D.
    [J]. DRUG RESEARCH, 2016, 66 (05) : 225 - 229
  • [10] Development of an Extended-Release Formulation of Capecitabine Making Use of In Vitro-In Vivo Correlation Modelling
    Meulenaar, Jelte
    Keizer, Ron J.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    Huitema, Alwin D. R.
    Nuijen, Bastiaan
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (02) : 478 - 484
12345